ArticlePDF Available

Abstract

Dysgerminoma tends to occur in young women although its incidence in pregnancy is low. Torsion and incarceration occurs in nearly half of the cases. Early diagnosis and appropriate treatment offers the best prognosis to the patient presenting with dysgerminoma. However because of enlarging abdominal size, pregnancy may mask the rapidly growing dysgerminoma often leading to late presentation. This is a case report of a female 30 years of age with stage 3C dysgerminoma which lead to acute surgical abdomen at 33weeks of pregnancy. Nepal Journal of Obstetrics and Gynaecology / Vol 7 / No. 1 / Issue 13 / Jan- June, 2012 / 53-55 DOI: http://dx.doi.org/10.3126/njog.v7i1.8838
53
NJOG / VOL 7 / NO. 1 / ISSUE 13/ Jan-June, 2012 | 53
CORRESPONDENCE
Dr Ajay Agrawal
Department of Obstetrics and Gynaecology
Assistant Professor, BPKIHS
Phone: 9852049451
Email: drajayagrawal@yahoo.com
Ovarian Dysgerminoma: Unusual Presentation in Pregnancy
with Acute Abdomen due to Internal Hemorrhage
Agrawal A,1 Rijal P,1 Pokharel H,1 Karki S,2 Basnet P,1 Dahal P1
1Dept of Obs/Gyn, 2Dept of Pathology, BPKIHS
Dysgerminoma tends to occur in young women although its incidence in pregnancy is low. Torsion and
incarceration occurs in nearly half of the cases. Early diagnosis and appropriate treatment offers the best
prognosis to the patient presenting with dysgerminoma. However because of enlarging abdominal size,
pregnancy may mask the rapidly growing dysgerminoma often leading to late presentation.
This is a case report of a female 30 years of age with stage 3C dysgerminoma which lead to acute surgical
abdomen at 33weeks of pregnancy.
Keywords : Acute abdomen, dysgerminoma, pregnancy with ovarian mass
INTRODUCTION
Dysgerminoma, which accounts for 1-5% of all ovarian
cancers, is the most commonly occurring malignant germ
cell tumor contribu ng to 28% of it.1 It tends to occur in
young women, though the incidence of pregnancy with
dysgerminoma is extremely low. The rate of malignant
tumors in the total number of ovarian tumors associated
with pregnancy was reported from 1.3% to 7.9%.2 Torsion
and incarcera on are common complica ons among
these rapidly enlarging tumors. Obstetrical complica ons
occurred in nearly half and fetal demise occurred in one
quarter of the reviewed cases.3
The 5-year survival rate is 96% if the tumor is con ned
to the ovary and 63% if extension occurs beyond the
ovaries. Pregnancy does not alter the prognosis of most
ovarian malignancies, but complica ons such as torsion
and rupture may increase the incidence of spontaneous
abor on or preterm delivery.4
CASE
A 30 years lady at 31 weeks and 5 days period of gesta on
referred from a primary health centre of Morang district
with ultrasound diagnosis of bilateral adnexal mass with
pregnancy was admi ed on 25th June 2011. She was
unbooked immunized G2 P1 L1 with previous uneven ul
pregnancy with normal vaginal delivery. She gave history of
dull aching lower abdominal pain and gradually increasing
abdominal distension since two weeks. She also had
occasional burning micturi on with increased frequency
and fever. She did not have history of loss of weight and
appe te. There was no family history of gynecologic
malignancy. There was no signi cant past medical or
surgical history. On examina on she was thin built and
looked pale. She had fever of 100˚F. Her respiratory and
cardiovascular systems were unremarkable. Abdomen was
grossly distended with fullness in bilateral anks. Uterus
was 34 weeks size with single live fetus in longitudinal
lie and cephalic presenta on. There was huge mass of
variegated consistency of around 15× 20cm with ill de ned
margin, restricted mobility, nontender on right side of
gravid uterus occupying whole of right hypochondrium
and similar but smaller mass of 10×8 cm in le ank. There
was no renal angle tenderness or palpable kidneys.
On inves ga on her hemoglobin was 7.4mg/dl,
urine culture had growth of E.Coli sensi ve to sulbactam+
cefoperazone, with which she responded and her fever
NJOG 2012 Jan-June; 7(3): 53-55
CASE REPORT
54
54 | NJOG / VOL 7 / NO. 1 / ISSUE 13/ Jan-June, 2012
subsided and other rou ne inves ga ons were within
normal limit. However her abdominal pain did not
subside. She was transfused with 3 units of whole blood.
She was given steroid coverage for fetal lung maturity.
An ultrasonography done on 1st July 2011 revealed large
abdominopelvic mass mostly solid in nature, 23×14 cm
in right side of abdomen and another solid mass 13×8.3
cm in pouch of Douglas with minimal ascites sugges ve
of bilateral adnexal mass with a single live fetus of 31-33
weeks of gesta on without any malforma ons. Addi onal
evalua on for serum CA125, AFP and βHCG was normal.
On 5th July, at 33 weeks of pregnancy she complained of
increasing abdominal pain which was con nuous and
generalized to whole abdomen not relieved with analgesic.
So with a diagnosis of twisted or ruptured ovarian mass
she was planned for lower segment caesarean sec on with
removal of ovarian mass and surgical staging. A er general
anesthesia, midline laparotomy incision was made. There
was hemoperitoneum of 2 liters with a super cial tumoral
vessel ac vely bleeding. A lower segment caesarean
sec on was rst performed.
Bosselated huge mass of 25×23×20cm was found
origina ng from right ovary and twisted around its pedicle
with mostly solid component extending from pouch of
Douglas to undersurface of liver. There were mul ple
metasta c deposits over parietal abdominal peritoneum
and omentum with dense adhesion to serosa of sigmoid
colon. No deposits were noted on surface of liver. ( Figure
1). Mass was removed a er haemosta c division of the
a achments and pedicle. The le ovary (4×1.5×1cm),
fallopian tube and uterus were grossly normal in contrast
to sonography diagnosis of bilateral ovarian mass.
Since she had no desire for future fer lity which was
discussed with her before taking her for laparotomy, a
total hysterectomy and bilateral salpingo-oophorectomy,
infracolic omentectomy with biopsy from parietal wall
was then performed. She delivered a preterm baby of 2
kg with apgar score of 7/10, 8/10 at 1 and 5 minutes of
life. Abdomen was closed with a drain in the pelvis. Post
opera ve period was uneven ul. Sutures were removed
on 8th post op day and drain was removed on 10th post
opera ve day.
Histopathology from right ovary revealed features of
malignant germ cell tumor having islands of large malignant
cells separated by scanty brous stroma and in ltrated
by lymphocytes, with areas of hemorrhages compa ble
with ovarian dysgerminoma. Uterus, Le ovary and both
fallopian tubes were histologically unremarkable. Sec ons
from omentum and abdominal wall also showed histologic
features of tumor deposits (Fig 2a,2b).
The pa ent was assigned FIGO Stage 3C ovarian malignancy
and referred to Bharatpur Cancer Hospital for pla num-
based chemotherapy.
COMMENT
Associa on of ovarian carcinoma with pregnancy is a
rare occurrence. It may also present as acute abdomen
because of torsion (tumor twis ng around its pedicle)
or intra-abdominal hemorrhage (from conges on and
rupture of super cial tumor vessels) as seen in this
pa ent.5 Early diagnosis and appropriate treatment o ers
the best prognosis to the pa ent. Bilateral tumors occur
in up to 10-15% of cases.6,7 Lee reported mean age of
23.8 years (range 4-63 years).8 Dysgerminoma is also very
sensi ve to radia on while other germ cell tumors are
not.9 Chemotherapy and/or radia on can be used to treat
pa ents with metasta c disease.5 For pa ents with early
Agrawal et al. Ovarian Dysgerminoma: Unusual Presentation in Pregnancy with acute Abdomen due to Internal Hemorrhage
Fig 1(a). Intraopera ve nding of huge ovarian mass with
the twisted pedicle. Fig 1 (b). Post partum uterus with ovarian dysgerminoma
with omentum
55
NJOG / VOL 7 / NO. 1 / ISSUE 13/ Jan-June, 2012 | 55
stage disease, cure rates approach 100%, while for those
with advanced-stage disease it is least 75%.9 Preopera ve
diagnosis depends mainly on age, abdominal symptoms,
size and consistency of the tumor, and elevated tumor
markers. Our pa ent had late presenta on as she was
misguided by the increase in abdominal size thinking it
to be due to pregnancy. The presenta on is usually with
chronic abdominal pain and palpable abdominal tumour.
Some may present with vaginal bleeding, amenorrhea or
precocious puberty.9
Elevated tumor markers may assist in determining the
diagnosis preopera vely.4 Hoei-Hansen et al reported the
expression of following markers in ovarian dysgerminomas:
placental alkaline phosphatase (PLAP) in 100% cases, stem
cell-related markers OCT-3/4 and KIT in 80% cases, and
NANOG and AP-2γ in 50% cases.4 Kawai et al reported
posi ve rate of AFP in 11.8% dysgerminoma, and CA 125
in over 50% cases; they also found a high posi ve rate
of LDH.10 In this case CA125, AFP and βHCG levels were
normal.
Surgery is the rst step of management followed by
adjuvant chemotherapy (depending on histopathology)
9. Appropriate surgical treatment for pa ents where
fer lity needs to be preserved consists of laparotomy
with unilateral salpingo-oophorectomy and resec on
of all visible disease.7,11 A total abdominal hysterectomy
is not mandatory, but may be performed concurrently if
pa ent does not desire future pregnancy as in this case.
The current standard adjuvant chemotherapy consists of 3
cycles of BEP.8,11 Four courses of BEP are recommended in
case of bulky residual tumor a er surgery.4,11 Recurrence
in contralateral ovary can develop over the next 2 years.7
Fer lity sparing treatments are considered safe in pa ents
with pure ovarian dysgerminomas.12
CONCLUSIONS
Ovarian cancer very rarely presents as an acute abdomen
in pregnancy. However, ovarian malignant dysgerminoma
may present as an acute abdomen because of torsion,
passive blood conges on, rupture of super cial tumoral
vessels and subsequent intra-abdominal hemorrhage.
Ovarian dysgerminoma should also be part of the
di eren al diagnosis in a young pregnant woman with
acute surgical abdomen and a solid heterogeneous pelvic
mass detected by ultrasonographic scan.
REFERENCES
1. Kdous M, Hachicha R, Gamoudi A, Boussen H, Benna F, Rahal K.
Pure dysgerminoma of the ovary. 12 case reports. Tunis Med.
2003;81(12):937-43 .
2. Creasman WT, Rutledge F, Smith JP. Carcinoma of the ovary
associated with pregnancy. Obstet Gynecol. 1971;38(1):111-6.
3. Karlen JR, Akbari A, Cook WA. Dysgerminoma associated with
pregnancy. Obstet Gynecol. 1979;53(3):330-5.
4. Lu KH, Gershenson DM. Update on the management of ovarian
germ cell tumours. J Reprod Med. 2005;50(6):417-25.
5. Varras M, Tsikini A, Polyzos D, Samara C, Akrivis C. Internal
hemorrhage caused by a twisted malignant ovarian dysgerminoma:
ultrasonographic ndings of a rare case and review of the
literature. Clin Exp Obstet Gynecol. 2004;31(1):73-8.
6. Hoei-Hansen CE, Kraggerud SM, Abeler VM, Kaern J, Rajpert De
Meyts E, Lothe RA. Ovarian dysgerminomas are characterised by
frequent KIT muta ons and abundant expression of pluripotency
markers. Mol Cancer. 2007;6:12.
7. Behtash N, Zarchi MK. Dysgerminoma in three pa ents with Swyer
syndrome. World J Surg Oncol. 2007;5:71.
8. Lee KH, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB et al.
Clinicopathologic characteris cs of malignant germ cell tumours
in the ovaries of Korean women: a Korean Gynecologic Oncology
Group Study. Int J Gynecol Cancer. 2009;19:84-7.
9. Aziz MF. Current management of malignant germ cell tumour of
the ovary. Gan To Kagaku Ryoho. 1995;22(Suppl 3):262-76.
10. Kawai M, Kano T, Kikkawa F, Morikawa Y, Oguchi H, Nakashima N
et al. Seven tumour markers in benign and malignant germ cell
tumours of the ovary. Gynecol Oncol. 1992;45(3):248-53.
11. Pectasides D, Pectasides E, Kassanos D. Germ cell tumours of the
ovary. Cancer Treat Rev. 2008;34(5):427-41.
12. Boran N, Tulunay G, Caliskan E, Kose MF, Haberal A. Pregnancy
outcomes and menstrual func on a er fer lity sparing surgery for
pure ovarian dysgerminomas. Arch Gynecol Obstet. 2005;271(2):
104-8.
Agrawal et al. Ovarian Dysgerminoma: Unusual Presentation in Pregnancy with acute Abdomen due to Internal Hemorrhage
Fig 2(a). Microscopically islands of large malignant cells
separated by scanty brous stroma
Fig 2(b). In ltrated by lymphocytes, with areas of
haemorrhage
... 3,5,6 Dysgerminoma, the malignant germ cell ovarian tumor is very rarely reported in association with pregnancy. 7,8 In a study by Ueda M et al of 106 cases of ovarian tumors associated with pregnancy who underwent surgery, five (4.7%) were malignant. Dermoid was the commonest lesion while dysgerminoma was noted in only one case. ...
... 13 Similarly Agrawal A et al reported an unusual case of stage 3C dysgerminoma in a young woman presenting as acute abdomen at 33 weeks of gestation. 8 The concerns are not just about the effect of malignancy on the natural course of pregnancy but also about implementing the appropriate management during pregnancy. Because of the rarity, most of the recommendations are drawn extrapolations from the experience with their corresponding testicular tumors and clear cut recommendations regarding their management in pregnancy are lacking. ...
... Recently, especially in developing and developed countries, age of mother in first pregnancy was significantly increased, and occurrence of pregnancy in mothers older than 30 and 40 years were raised, significantly. Therefore, it is not specified, whether development of ovarian malignant tumor in pregnancy period is raising (Matsuyama et al. 1989), or tendency to pregnancy and childbearing in old age is accepted (Agrawal et al. 2012). This general interest causes increase of development of ovarian malignant tumor during to pregnancy period (Leslie 2002;Ferrandina et al. 2005;Méndez et al. 2003). ...
Article
Full-text available
One of the least common malignant ovarian tumors detected during pregnancy is dysgerminoma. The association between creation dysgerminoma and pregnancy was controversial. We present here a rare and interesting case of dysgerminoma during pregnancy with literature review. A 29-year-old healthy pregnant woman presented with an acute progressive abdominal pain. The patient underwent laparotomy and left salpingo oophorectomy. A diagnosis of dysgerminoma (FIGO stage IA) was made. She had uneventful postoperative period. She referred for subsequent chemotherapy. The surgeons and radiologists, particularly at major referral emergency centers, are much more likely to be acquaint with ovarian dysgerminoma, as a solid nonhomogenous pelvic mass discovered by ultra-sonography in pregnant woman and its clinical awareness, because any misdiagnosis can delay the start of an appropriate and adequate management.
Article
Full-text available
Ovarian germ cell tumours (OGCTs) typically arise in young females and their pathogenesis remains poorly understood. We investigated the origin of malignant OGCTs and underlying molecular events in the development of the various histological subtypes of this neoplasia. We examined in situ expression of stem cell-related (NANOG, OCT-3/4, KIT, AP-2gamma) and germ cell-specific proteins (MAGE-A4, NY-ESO-1, TSPY) using a tissue microarray consisting of 60 OGCT tissue samples and eight ovarian small cell carcinoma samples. Developmental pattern of expression of NANOG, TSPY, NY-ESO-1 and MAGE-A4 was determined in foetal ovaries (gestational weeks 13-40). The molecular genetic part of our study included search for the presence of Y-chromosome material by fluorescence in situ hybridisation (FISH), and mutational analysis of the KIT oncogene (exon 17, codon 816), which is often mutated in testicular GCTs, in a subset of tumour DNA samples. We detected a high expression of transcription factors related to the embryonic stem cell-like pluripotency and undifferentiated state in OGCTs, but not in small cell carcinomas, supporting the view that the latter do not arise from a germ cell progenitor. Bilateral OGCTs expressed more stem cell markers than unilateral cases. However, KIT was mutated in 5/13 unilateral dysgerminomas, whereas all bilateral dysgerminomas (n = 4) and all other histological types (n = 22) showed a wild type sequence. Furthermore, tissue from five phenotypic female patients harbouring combined dysgerminoma/gonadoblastoma expressed TSPY and contained Y-chromosome material as confirmed by FISH. This study provides new data supporting two distinct but overlapping pathways in OGCT development; one involving spontaneous KIT mutation(s) leading to increased survival and proliferation of undifferentiated oogonia, the other related to presence of Y chromosome material and ensuing gonadal dysgenesis in phenotypic females.
Article
Seven tumor markers were analyzed clinically in 135 patients with germ cell tumors of the ovary who were treated in Tokai Ovarian Tumor Study Group, an association comrising Nagoya University and its affiliated hospitals, between January 1979 and September 1990. Positive rate of AFP was 100% () in yolk sac tumor, 61.9% () in immature teratoma, and 11.8% () in dysgerminoma, but there were no positive cases of mature cystic teratoma with malignant transformation () and mature cystic teratoma (). Positive rate of CA125 was over 50% in all tumor types except mature cystic teratoma, which showed a positive rate of 23.7%. CA125 was useful for the screening of malignant germ cell tumors. CA19-9 showed a high positive rate in teratomatous tumors, which were immature teratoma, mature cystic teratoma with malignant transformation, and mature cystic teratoma. Dysgerminoma and yolk sac tumor, especially dysgerminoma, had a high positive rate of LDH. TPA and CEA were not considered useful tumor markers for germ cell tumors of the Ovary.
Article
From January 1995 to December 2000, medical records of 196 patients were collected from 14 hospitals nationwide and were reviewed retrospectively. We evaluated the clinicopathologic characteristics of malignant germ cell tumors in the ovaries of South Korean women and determined the prognostic factors affecting recurrence. The mean patient age was 23.8 years (range, 4-63 years), and the median follow-up period was 67 months (range, 1-128 months). The distribution of the International Federation of Gynecology and Obstetrics stage was as follows: 128 cases (65.3%) in stage I, 27 cases (13.8%) in stage II, 39 cases (19.9%) in stage III, and 2 cases (1.0%) in stage IV. Histologically, immature teratoma was the most common tumor type (n = 68), followed by dysgerminoma (n = 54), endodermal sinus tumor (n = 38), mixed form (n = 24), and choriocarcinoma (n = 12). A fertility-sparing operation was performed in 134 patients, staging operation in 43 patients, and hysterectomy and bilateral salpingo-oophorectomy in 19 patients. Postoperative chemotherapy was administered in 166 patients, and the most common regimen was bleomycin, etoposide, and cisplatin (n = 120). Recurrence was observed in 13 patients (6.8%) and was influenced by the stage of the tumor and patient age (>40 years). The 5-year survival rate was 96.7%. During the follow-up period, 20 patients had 22 pregnancies that resulted in 17 normal deliveries at term and 5 abortions. The results of this study demonstrate that most malignant germ cell tumors of the ovary in Korean women are detected in the early stage and have excellent survival outcomes with conservative operation and platinum-based chemotherapy.
Article
From a review of 26 reported case (our case being the 27th) of dysgerminoma associated with pregnancy, several salient facts are evident. Torsion and incarceration are common among these rapidly enlarging tumors. Obstetrical complications occurred in nearly half and fetal demise in one quarter of the reviewed cases. Our case was typical of patients presenting with this vexed problems: The patient was under 25 (as were 70%); nulliparous (as were 67%); and the tumor appeared confined to one ovary (as in 89%). Authorities are in dispute as to the treatment of stage IA dysgerminomas, and the association of pregnancy complicates this debate even further. The results of conservative treatment in this series were jarring: There were recurrences in 30% of the 23 stage IA tumors, and the recurrences were all following unilateral oophorectomy. In our case, the grossly normal contralateral ovary was infiltrated with dysgerminoma cells. While treatment of a young woman with a dysgerminoma of 1 ovary is a matter of perplexity, we believe that a unilateral operation should be limited to those women who desire above all earthly things to retain their childbearing capacity.
Article
Ovarian carcinoma associated with pregnancy is an unusual but not a rare occurrence. In these patients, an earlier stage of the disease was noted, with several being asymptomatic when the adnexal mass was found during the routine prenatal survey. Unusual ovarian tumors, such as dysgerminoma and granulosa cell tumor, account for a higher proportion of neoplasms than the ovarian cancer population overall. The early stage of disease, the 100% survival of germ cell tumors and aggressive management all seem to be important factors in the higher-than-expected survival in this small group of patients. © 1971 The American College of Obstetricians and Gynecologists.
Article
Malignant germ cell tumors are an uncommon type of ovarian cancer which account for fewer than 5% of the total in Western countries and 20% in Japan. In females younger than 20, they represent approximately two-thirds of malignant ovarian tumors. Immature teratoma, endodermal sinus tumor, dysgerminoma and mixed type account for the majority (more than 80%), while embryonal carcinoma and polyembryoma are very few. The age of the patients ranges from 6 to 69 years with a median of 16-20 years. Clinically, these tumors are characterized by rapid growth and extensive intraabdominal spread. The symptoms and signs range from 1 day to 6 months with a median of 4 weeks, and the patients usually present with abdominal pain, palpable mass, abdominal distention and vaginal bleeding, and a very few with amenorrhea and precocious puberty. The size of tumors varies from 7 cm to 40 cm with a median of 15-16 cm. The tumor is rarely bilateral (12-19%) and never so in cases of endodermal sinus tumor. Diagnosis depends mainly on age, abdominal symptoms, size and consistency of the tumor, and tumor markers AFP and hCG. Surgery is the first step of management followed by adjuvant therapy, which depends on the histologic type. Dysgerminoma is very sensitive to radiation while other germ cell tumors are not. A combination chemotherapy currently used is VAC or VBP. Both are highly effective. The VBP regimen seems to have a stronger cancerocidal effect, while the VAC regimen is less toxic. VAC produces excellent results in stage I, while VBP is more effective for advanced disease. Conservative surgery and a combination chemotherapy (VAC, VBP) are appropriate for young patients who desire to retain their fertility. Second-look laparotomy is still controversial. As long as AFP or hCG or both can be used to monitor the disease in patients positive for these sensitive and reliable markers, or in an early stage with complete resection, second-look laparotomy is not useful. Survival is associated with prognostic factors, i.e., histologic type, clinical staging operation, lymph node and residual tumor. Patients with endodermal sinus tumor or mixed type tumor had a poorer outcome. The survival rate was higher in patients with earlier disease (stage I or II) and those who underwent primary surgery. Metastasis to the lymph node is not related to prognosis. The presence and size of residual tumors after surgery were closely related to the prognosis.
Article
Unlabelled: Data from the files of 12 patients with pur ovarian dysgerminoma managed between January 1970 and december 1990 were evaluated. Pur ovarian dysgerminoma accounts for 2% of all ovarian malignancies and 28% of malignant germ cell tumors. A palpable pelvic mass was detected in three-fourth of patients. Echography objective ovarian tumor in all cases. Diagnosis was histological. Primary treatment was surgery followed by radiotherapy in 8 cases and chemotherapy in 2 cases. 2 patients developed local recurrences were irradiated and 1 patient developed distant metastases was given chemotherapy in association to radiotherapy. The 5 years survival rate was 91.7%. Conclusion: Treatment of ovarian dysgerminoma remains controversial. However, patients with stage la who desire further childbearing can be safely treated with unilateral adnexectomy. For all other patients, radical surgery followed by radiation therapy or chemotherapy for the advanced stages and recurrents dysgerminoma is the treatment of choice. Prospective randomized clinical trials are needed for a well codified therapeutic strategy.
Article
Ovarian cancer presents as an acute abdomen very rarely. The purpose of the study is the description of a right ovarian malignant dysgerminoma presenting as an abdominal emergency. A 16-year-old white female presented with acute abdominal pain in the right iliac fossa. On physical examination the abdomen was acute and a mass in the right lower abdomen was palpated. The patient was sexually active and bimanual gynecological examination revealed the presence of a large lobulated solid tumor in the position of the right adnexa. Ultrasound examination showed the presence of a large, multilobulated, heterogeneous, predominantly solid pelvic mass. Color flow imaging showed intratumoral flow signals. The uterus and the left ovary had normal size and echo-texture. Fluid was found in the cul-de-sac and in Morisson's space. An immediate exploratory laparotomy exposed the presence of a twisted right ovarian mass and intraperitoneal hemorrhage. A superficial tumoral vessel actively bleeding was seen. Peritoneal fluid was obtained for cytology. The intra-abdominal hemorrhage ceased when the ovarian pedicle was clamped. The patient underwent right salpingo-oophorectomy and biopsy of the omentum. Pathologic analysis revealed a malignant dysgerminoma of the right ovary, expanding to the mesosalpinx. Cytology was positive for malignancy. Postoperative CT scan of the upper and lower abdomen was negative. The patient was assigned to FIGO Stage IIC and referred for platinum-based chemotherapy. Ovarian malignant dysgerminoma may present as an acute abdomen because of torsion, passive blood congestion, rupture of superficial tumoral vessels and subsequent intra-abdominal hemorrhage. Ovarian dysgerminoma should be part of the differential diagnosis in a young woman with acute surgical abdomen and a solid heterogeneous pelvic mass detected by ultrasonographic scan.
Article
The medical records of 23 patients with pure ovarian dysgerminoma treated by conservative surgery at SSK Ankara Maternity Hospital between 1991 and 2001 were reviewed retrospectively. Pregnancy outcomes and menstrual function after conservative surgery were analyzed. Seven patients (30%) were incompletely staged and were assumed to be stage IA due to intraoperative findings. Fifteen patients (70%) were surgically staged. As a result 15 patients (65.2%) were diagnosed to be stage I while 2 patients (8.6%) were staged II and 6 patients (26%) were staged III. Wedge biopsy of contralateral ovary was performed in 17 patients (74%) and tumor was diagnosed in 2 (11.7%). Adjuvant chemotherapy was applied in 16 (70%) of the cases. BEP (bleomycin, etoposide, and cisplatin) was the most frequently used regimen (39%). Recurrences were seen in 3 (13%) patients. The sites of recurrences were contralateral ovary in all cases. Recurrences were treated with surgery and radiotherapy. None of the patients died of disease. Nine patients were sexually active. Five of these patients had prior live births. Three of the primiparous patients delivered after treatment. Five pregnancies occurred in 3 nulliparous patients at the time of primary surgery. Three of these reached term and healthy babies were delivered. One pregnancy was terminated at 18 weeks of gestation due to anencephaly and a dilatation and curettage was performed at 6th week in another patient. Menstrual problems occurred in 4 (17.3%) of the 23 patients. Fertility sparing treatments are safe in patients with pure ovarian dysgerminoma.
Article
Malignant germ cell tumors of the ovary are rare. In contrast to epithelial ovarian cancer, malignant germ cell tumors occur primarily in girls and young women. In addition, with the refinement of chemotherapeutic regimens in the last several decades, overall disease-free survival rates are >95%. Recent advances have focused on preservation of fertility in the management of patients with these tumors. In a girl or young woman who presents with a pelvic mass, a gynecologist must consider the diagnosis of an ovarian germ cell tumor in the initial workup. Elevated tumor markers may assist in determining the diagnosis preoperatively. Appropriate intraoperative decision making is crucial to adequately treat and stage the cancer without compromising future fertility. For patients with stage I dysgerminoma or stage I low grade immature teratoma, no additional chemotherapy is indicated. However, patients with stage I disease of other germ cell histologies, as well as advanced-stage disease of all germ cell histologies, require adjuvant treatment with bleomycin, etoposide and cisplatin.